Showing results (81-90 of 177) with videos related to
Sort By:
Pageof 18
Radiology and Oncology|January 4, 2025
The financial toxicity of breast cancer: a systematic mapping of the literature and identification of research challengesIvica Ratosa, Mojca Bavdaz, Petra Dosenovic Bonca, et al.Journal of Geophysical Research. Solid Earth|July 22, 2022
The High-Frequency Signature of Slow and Fast Laboratory EarthquakesDavid C Bolton, Srisharan Shreedharan, Gregory C McLaskey, et al.Nature Communications|December 24, 2014
Using ultrashort optical pulses to couple ferroelectric and ferromagnetic order in an oxide heterostructureY M Sheu, S A Trugman, L Yan, et al.Trends in Ecology & Evolution|March 6, 2021
Why is Tree Drought Mortality so Hard to Predict?Anna T Trugman, Leander D L Anderegg, William R L Anderegg, et al.JAMA|November 20, 2019
Effect of Ubrogepant vs Placebo on Pain and the Most Bothersome Associated Symptom in the Acute Treatment of Migraine: The ACHIEVE II Randomized Clinical TrialRichard B Lipton, David W Dodick, Jessica Ailani, et al.The New England Journal of Medicine|December 5, 2019
Ubrogepant for the Treatment of MigraineDavid W Dodick, Richard B Lipton, Jessica Ailani, et al.Headache|September 1, 2023
Safety and efficacy of ubrogepant for the acute treatment of perimenstrual migraine attacks: A post hoc analysisE Anne MacGregor, Susan Hutchinson, Hongxin Lai, et al.Therapeutic Advances in Musculoskeletal Disease|July 17, 2013
Milnacipran combined with pregabalin in fibromyalgia: a randomized, open-label study evaluating the safety and efficacy of adding milnacipran in patients with incomplete response to pregabalinPhilip J Mease, Mildred V Farmer, Robert H Palmer, et al.Physical Review Letters|July 20, 2001
Ultrafast conductivity dynamics in colossal magnetoresistance manganitesR D Averitt, A I Lobad, C Kwon, et al.The Lancet. Neurology|August 22, 2020
Safety, tolerability, and efficacy of orally administered atogepant for the prevention of episodic migraine in adults: a double-blind, randomised phase 2b/3 trialPeter J Goadsby, David W Dodick, Jessica Ailani, et al.Pageof 18